Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia
Study Details
Study Description
Brief Summary
Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: control group Participants will receive the descriptive medication by neurologist |
|
| Experimental: electromagnetic group Participants will receive the descriptive medication by neurologist in addition to electromagnetic therapy. Electromagnetic therapy will be applied for 20 min/session for three days each week for two months. |
Other: Electromagnetic therapy.
Electromagnetic therapy will be applied for 20 min/ session for (3 days/ week for two months) to the group intervention.
|
| Experimental: low laser therapy group Participants will receive the descriptive medication by neurologist in addition to low laser therapy. Low laser therapy will be applied for 20 min/session for three days each week for two months. |
Other: Low level laser therapy (LLLT)
Low level laser therapy (LLLT) will be applied for 20 min/session laser scanner for three days each week for two months to the group intervention.
|
Outcome Measures
Primary Outcome Measures
- Studies using electromyography and complex muscle action potentials [at the beginning of the study]
All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated before interventions.
- Studies using electromyography and complex muscle action potentials [by the end of successful two month of intervention]
All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated after two month of interventions.
- Visual analogue scale (VAS) [at the beginning of the study]
All the participants were instructed to express their pain by Visual analogue scale (VAS) before the interventions.
- Visual analogue scale (VAS) [by the end of successful two month of intervention]
All the participants were instructed to express their pain by Visual analogue scale (VAS) after two month of interventions.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All participants will between the ages of 25 and 45, will of both sexes (male and female), diabetic type two patients with chronic trigeminal neuralgia, (from three to six months).
-
Patients will awake, cooperative, and free of psychiatric issues (as determined by a psychologist) as well as difficulties resulting from orthopaedic or special sensory deficits.
Exclusion Criteria:
-
Patients will ruled out if they developed TN due to a tumour, herpes zoster, or any other reason other than diabetes, such as significant coagulation dysfunction, cardiopulmonary dysfunction or previous invasive treatment (ethanol, radiofrequency, Gama-knife microvascular decompression, glycerinum injection).
-
They will not have a previous disability in the face.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | AAA | Cairo | Egypt |
Sponsors and Collaborators
- Delta University for Science and Technology
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- magnetic and laser therapy